Proposed US Spending Bill Boosts Science Funding

NIH, NSF, and the DOE’s Office of Science will be among the agencies with budget increases if the omnibus bill is passed.

Written byShawna Williams
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

US capitol buildingFLICKR, ARCHITECT OF THE CAPITOLUpdate (March 23): The Senate and House of Representatives have both passed the spending bill, and President Trump is expected to sign it into law.

A $1.3-trillion spending agreement reached yesterday (March 21) includes funding increases for most US science funding agencies, including the National Institutes of Health (NIH), National Science Foundation (NSF), and NASA. The House of Representatives is expected to vote on the bill today.

“Research!America applauds the unprecedented boost in funding for the National Institutes of Health (NIH) and significant increases for other federal health agencies in FY18 to accelerate medical progress, public health and scientific innovation,” Research!America President and CEO Mary Woolley says in a statement. “The omnibus bill is a positive step forward in strengthening our global competitiveness and our nation's commitment to research and public health.”

The bill, which covers federal spending for the current fiscal year, would increase the NIH budget by $3 ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • Shawna was an editor at The Scientist from 2017 through 2022. She holds a bachelor’s degree in biochemistry from Colorado College and a graduate certificate in science communication from the University of California, Santa Cruz. Previously, she worked as a freelance editor and writer, and in the communications offices of several academic research institutions. As news director, Shawna assigned and edited news, opinion, and in-depth feature articles for the website on all aspects of the life sciences. She is based in central Washington State, and is a member of the Northwest Science Writers Association and the National Association of Science Writers.

    View Full Profile
Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies